✔ COMPLIANT
★☆☆
Pharmaceuticals | UK
Business: PASS
GlaxoSmithKline PLC has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.
Financials: PASS
The financials pass just one standard and fail in the other two.
FTSE
| Debt/A | 30.56% | ✔ |
| Cash/A | 5.4% | ✔ |
| (AR+C)/A | 5.4% | ✔ |
AAOIFI
| Debt/MC | 30.19% | ✘ |
| Cash/MC | 0.08% | ✔ |
DJIM
| Debt/24MC | 33.51% | ✘ |
| Cash/24MC | 5.92% | ✔ |
| AR/24MC | % |
Total Analysts: 26
Recommendation Rating
1
2
3
4
5
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Analysts’ Price Targets
Low: 18.9
High: 29.4
| Market cap | 108308750196 |
| Assets | 107018873030 |
| Dividends per Share | 1.08 |
| Revenue Growth | 4.2 |
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
| ✔ FTSE | ✘ AAOIFI | ✘ DJIM |
✔ COMPLIANT
We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.
Responses